In the News | Friends of Cancer Research

You are here

In the News

August 12, 2019
Recent US Food and Drug Administration (FDA) draft guidance on enhancing clinical trial populations’ diversity should discuss the role of real-world data/evidence (RWD/RWE), comments to FDA say.The... Read more
August 5, 2019
Historically, getting patients in clinical trials is the biggest challenge to healthcare breakthrough. But now data can used to replace patients in clinical trials. A key priority for the life... Read more
July 15, 2019
Clinical trials can be less reflective of the general population with cancer, due to the exclusion of those with certain comorbidities. The use of expanded clinical trial inclusion criteria would... Read more
July 13, 2019
Cancer clinical trials have been notoriously exclusive, and for years there has been no exception when it comes to patients with HIV. However, according to recent research, patients with lymphoma,... Read more
July 12, 2019
External control arms are moving from theory to practice as drug developers begin to use them to make internal go/no-go decisions for clinical programs and to support regulatory applications. The... Read more
July 12, 2019
The bill, H.R. 913, was introduced in the House of Representatives by Rep. Ben Ray Lujan (D-NM) and Rep. Gus Bilirakis (R-FL). “Clinical trials have tremendous potential to help patients with life-... Read more
July 10, 2019
Pilot Project Will Provide Novel Analysis in Partnership With 10 Leading Healthcare Research Organizations Friends of Cancer Research (Friends) is launching the next phase of our Real-World Evidence... Read more
June 25, 2019
A DIAGNOSIS of any life-threatening cancer or other serious illness has always been a world-shaking event for those touched by significant disease, and most of us have known—or will know—the... Read more
June 25, 2019
The immune checkpoint inhibitor Keytruda (pembrolizumab) was found to be a safe treatment for different cancer types among people living with HIV, data from a Phase 1 trial show.   The results are... Read more
June 20, 2019
Cellular advances in the field of immunotherapy such as chimeric antigen receptor (CAR) T-cell therapy and tumor-infiltrating lymphocytes are generating great interest in oncology even as scientists... Read more